TEM ▲ +1.2% - Tempus AI, Inc. $TEM RXRX - Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model Tempus AI shares rose 1.2% following news that the company extended its existing data license agreement with Recursion Pharmaceuticals and entered into a new license agreement covering Recursion's RNA foundation model. The expanded partnership signals deepening collaboration between the two AI-driven drug discovery platforms and validates demand for Tempus's data assets in the generative AI drug development space. 21-SEP-2026 09:23 AM ET